Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5UR7

Crystal structure of engineered CCL20 disulfide locked dimer

5UR7 の概要
エントリーDOI10.2210/pdb5ur7/pdb
分子名称C-C motif chemokine 20, ACETATE ION, ISOPROPYL ALCOHOL, ... (4 entities in total)
機能のキーワードccl20, chemokine, macrophage inflammatory protein-3 alpha, mip3-alpha, chemotaxis, psoriasis, locked dimer, cytokine, immune system
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数2
化学式量合計16474.58
構造登録者
Getschman, A.E.,Peterson, F.C.,Volkman, B.F. (登録日: 2017-02-09, 公開日: 2017-11-22, 最終更新日: 2024-10-23)
主引用文献Getschman, A.E.,Imai, Y.,Larsen, O.,Peterson, F.C.,Wu, X.,Rosenkilde, M.M.,Hwang, S.T.,Volkman, B.F.
Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.
Proc. Natl. Acad. Sci. U.S.A., 114:12460-12465, 2017
Cited by
PubMed Abstract: Psoriasis is a chronic inflammatory skin disease characterized by the infiltration of T cell and other immune cells to the skin in response to injury or autoantigens. Conventional, as well as unconventional, γδ T cells are recruited to the dermis and epidermis by CCL20 and other chemokines. Together with its receptor CCR6, CCL20 plays a critical role in the development of psoriasiform dermatitis in mouse models. We screened a panel of CCL20 variants designed to form dimers stabilized by intermolecular disulfide bonds. A single-atom substitution yielded a CCL20 variant (CCL20 S64C) that acted as a partial agonist for the chemokine receptor CCR6. CCL20 S64C bound CCR6 and induced intracellular calcium release, consistent with G-protein activation, but exhibited minimal chemotactic activity. Instead, CCL20 S64C inhibited CCR6-mediated T cell migration with nominal impact on other chemokine receptor signaling. When given in an IL-23-dependent mouse model for psoriasis, CCL20 S64C prevented psoriatic inflammation and the up-regulation of IL-17A and IL-22. Our results validate CCR6 as a tractable therapeutic target for psoriasis and demonstrate the value of CCL20 S64C as a lead compound.
PubMed: 29109267
DOI: 10.1073/pnas.1704958114
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.0004 Å)
構造検証レポート
Validation report summary of 5ur7
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon